MoleculeMind
Latest round
- Series A
Last raised
- Jun 2026
Total raised
- Undisclosed
Investors
- 20
About MoleculeMind
, doing business named MoleculeMind, is a biopharmaceutical company that focuses on the fields of artificial intelligence (AI) protein design. Professor Xu Jinbo, the company's founder, served as a professor at the University of Chicago. The company has cooperated with National Labs, the Chinese Academy of Sciences, and other research institutions to establish the dry and wet labs. It also collaborated with pharmacy corporation, such as Merck, and Roche, to explore AI drug research for gene therapy, and antibody therapy. MoleculeMind developed an AI macromolecule optimization and design platform, MoleculeOS, which uses a data-driven deep learning approach to help biotechnologists identify and generate proteins. The platform can be used for research and design of peptides, antibodies, enzymes, and small proteins and for protein optimization and design in chemistry, materials, synthetic biology, industry, agriculture, and other fields. The company generates revenue through AI protein design platforms, software and API-based tools, technical services, and industry-specific design solutions for life sciences and industrial biotechnology users.
Who invested in MoleculeMind
20 investors across 3 rounds
See all investors in MoleculeMind
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about MoleculeMind
Who invested in MoleculeMind?
MoleculeMind has 20 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MoleculeMind raised?
MoleculeMind has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did MoleculeMind last raise money?
MoleculeMind's most recent round on record is a Series A, in Jun 2026.
What does MoleculeMind do?
, doing business named MoleculeMind, is a biopharmaceutical company that focuses on the fields of artificial intelligence (AI) protein design.
Where is MoleculeMind headquartered?
MoleculeMind is headquartered in Beijing, China.
Which VCs invest in companies like MoleculeMind?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at MoleculeMind's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like MoleculeMind? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.